23 June 2020>: Clinical Research
The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis
Mei Tian 1BE* , Xiuchun Yang 1CD* , Yanfang Li 1BF , Sen Guo 2ABCDEFG*DOI: 10.12659/MSM.923359
Med Sci Monit 2020; 26:e923359
Table 4 Multivariate analysis was performed to confirm the independent prognostic factors.
Characters | HR | 95% CI | P* |
---|---|---|---|
Tumor size (cm) | |||
≤5 | 1 | ||
>5 | 1.21 | 0.74–1.98 | 0.446 |
Vascular invasion | |||
Negative | 1 | ||
Positive | 1.51 | 0.98–2.31 | 0.06 |
T stage | |||
I+II | 1 | ||
III+IV | 2.90 | 1.80–4.69 | |
Dynamin 1 | |||
Low | 1 | ||
High | 2.06 | 1.36–3.12 | 0.001 |
* Analyzed with the Cox-regression model. HBsAg – hepatitis B surface antigen; HCV – hepatitis C virus; AFP – alpha fetoprotein; HR – harzrd ratio; CI – confidential incidence. |